96 related articles for article (PubMed ID: 8687466)
21. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
Yue TL; Rabinovici R; Farhat M; Feuerstein G
J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
[TBL] [Abstract][Full Text] [Related]
22. Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs.
Sugimoto Y; Nakayama Y; Kishida H; Hayakawa T; Fujiwara R; Kamei C
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):547-52. PubMed ID: 9442478
[TBL] [Abstract][Full Text] [Related]
23. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
[TBL] [Abstract][Full Text] [Related]
25. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Saeed SA; Rasheed H
Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
[TBL] [Abstract][Full Text] [Related]
26. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons.
DeCoster MA; Mukherjee PK; Davis RJ; Bazan NG
J Neurosci Res; 1998 Aug; 53(3):297-303. PubMed ID: 9698157
[TBL] [Abstract][Full Text] [Related]
27. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
Hu W; McNicholl IK; Choy PC; Man RY
Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves.
da Silva MB; Dessy C; Coghe J; David JL; Lekeux P
Vet Res Commun; 1998 Jun; 22(4):273-91. PubMed ID: 9686442
[TBL] [Abstract][Full Text] [Related]
29. A novel receptor for platelet-activating factor and lysophosphatidylcholine in Trypanosoma cruzi.
Coelho FS; Oliveira MM; Vieira DP; Torres PHM; Moreira ICF; Martins-Duarte ES; Gonçalves IC; Cabanelas A; Pascutti PG; Fragoso SP; Lopes AH
Mol Microbiol; 2021 Sep; 116(3):890-908. PubMed ID: 34184334
[TBL] [Abstract][Full Text] [Related]
30. Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
Sahu RP
Mol Med Rep; 2015 Jul; 12(1):394-400. PubMed ID: 25695262
[TBL] [Abstract][Full Text] [Related]
31. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
Adamus WS; Heuer H; Meade CJ
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
Borman RA; Jewell R; Hillier K
Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
[TBL] [Abstract][Full Text] [Related]
34. Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells.
Zhang F; Liu L; Zhang H; Liu ZL
Drug Des Devel Ther; 2020; 14():4205-4214. PubMed ID: 33116408
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
[TBL] [Abstract][Full Text] [Related]
36. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
37. Effects of platelet-activating factor on intracellular Ca2+ concentration and contractility in isolated cardiomyocytes.
Pietsch P; Hunger T; Braun M; Roediger A; Baumann G; Felix SB
J Cardiovasc Pharmacol; 1998 May; 31(5):758-63. PubMed ID: 9593076
[TBL] [Abstract][Full Text] [Related]
38. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
40. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
